Centring sexual and reproductive health and justice in the global COVID-19 response.
Kelli Stidham Hall, Goleen Samari, Samantha Garbers...
https://pubmed.ncbi.nlm.nih.gov/32278371/Actively Recruiting
Led by Emory University · Updated on 2026-06-15
400
Participants Needed
4
Research Sites
N/A
Total Duration
This research aims to evaluate the effectiveness of an evidence-based approach called Screening, Brief Intervention, and Referral to Treatment SBIRT among adult patients who screen positive for risky alcohol or substance use behaviors while seeking care at sexual and reproductive health clinics. The study focuses on whether SBIRT can improve patients alcohol and substance use, sexual and reproductive health, mental and physical health, quality of life, and wellbeing. It also explores if SBIRTs impact varies by ethnicity, socioeconomic status, age, gender, urbanicity, and delivery mode in-person vs. telemedicine. Participants are randomly assigned to receive either the SBIRT intervention delivered both in-person and via telemedicine or usual care, which lacks a standardized screening or treatment approach. The SBIRT intervention includes validated screening tools, brief motivational interviewing-based interventions lasting 5 to 10 minutes, and referrals to specialty addiction treatment for severe cases. The study is conducted within a large family planning clinic network serving a diverse population of reproductive-aged individuals. During the study, participants complete surveys and interviews at baseline, 30 days, and 3 months to assess various outcomes such as alcohol and drug use frequency, sexual behaviors under influence, mental health status, and wellbeing. Researchers also monitor the implementation and use of SBIRT by clinics and providers over a 12-month period. The trial aims to provide guidance on scaling integrated alcohol and substance use services in sexual and reproductive health settings, promoting health equity among reproductive-aged populations.
CONDITIONS
Improving Alcohol and Substance Use Care Access, Outcome, Equity During the Reproductive Years
K
Kelli S Hall, PhD MS
J
Jessica LaHote, MPH
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Emory University
Lead Sponsor
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Collaborating Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | SBIRT | Usual Care |
|---|---|---|
| What it is | SBIRT combines validated screening tools, a brief motivational interview, and structured referral to addiction treatment, adapted for telemedicine visits. | Usual Care is routine screening and counseling for risky substance use, following standard practices without structured SBIRT protocols. |
| Role in Trial | SBIRT is the investigational intervention tested to improve access and outcomes for alcohol and substance use screening and care during the reproductive years. | Usual Care serves as the comparator, reflecting standard practice approaches used outside the SBIRT protocol. |
| Primary Use | Used to identify and address risky alcohol and substance use, deliver brief intervention, and assist referral to addiction treatment through telemedicine. | Intended to detect risky behaviors and provide advice or minimal intervention, but without formalized SBIRT structure or referral approach. |
| How it is given or performed | Delivered through telemedicine using validated screening instruments, brief motivational interviewing, and direct referral, requiring 5–10 minutes for the intervention. | Typically administered during routine healthcare visits, screening may occur via clinician questions or forms, advice or brief counseling given if risky use detected. |
| Evidence Status | SBIRT is supported by evidence from multiple studies and guidelines, showing moderate effectiveness in reducing risky alcohol use and supporting behavioral change in clinical settings, especially when implemented in women's health clinics. | Usual Care has variable published effectiveness, with studies indicating inconsistent screening practices and missed opportunities for intervention in women's health settings. |
| Important Limitations | SBIRT effectiveness relies on consistent implementation, provider training, and patient acceptance. Telemedicine delivery may miss participants with limited access or engagement, and time constraints affect intervention quality. | Usual Care often fails to consistently screen or intervene; providers may skip screening or lack referral options. Potential gaps in care delivery and variable follow-up limit impact. |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person or virtual)
Duration - 3 months
Participants receive either the SBIRT intervention delivered in-person and through telemedicine, or usual care without standardized screening or treatment.
Surveys and interviews at baseline, 30 days, and 3 months
Duration - 12 months
Researchers track the use of SBIRT by clinics and providers during a 12-month implementation and sustainment phase.
Ongoing data collection during implementation and sustainment
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Kelli Stidham Hall, Goleen Samari, Samantha Garbers...
https://pubmed.ncbi.nlm.nih.gov/32278371/Jean Y Ko, Sara Wolicki, Wanda D Barfield...
https://pubmed.ncbi.nlm.nih.gov/28278146/Mishka Terplan, Maayan Lawental, Melanie Bryant Connah...
https://pubmed.ncbi.nlm.nih.gov/26690290/Scott E Hadland, Sarah H Copelas, Sion K Harris
https://pubmed.ncbi.nlm.nih.gov/28196680/P D Friedmann, D McCullough, M H Chin...
https://pubmed.ncbi.nlm.nih.gov/10672110/Jennifer J Frost, Rachel Benson Gold, Amelia Bucek
https://pubmed.ncbi.nlm.nih.gov/23122212/Jennifer Hettema, Stephanie Cockrell, Jennifer Russo...
https://pubmed.ncbi.nlm.nih.gov/26230758/A G Thomas, S K Brodine, R Shaffer...
https://pubmed.ncbi.nlm.nih.gov/11755563/Bryan R Garner, Mark Zehner, Mathew R Roosa...
https://pubmed.ncbi.nlm.nih.gov/29149909/Sara J Becker, Cara M Murphy, Bryan Hartzler...
https://pubmed.ncbi.nlm.nih.gov/34635178/Emory University
Lead Sponsor
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Collaborating Sponsor